Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2022-12-07 00:00:00 ET · period of report 2022-12-05 · accession 0001765581-22-000136 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-07 | 2022-12-05 | JAZZ | Swisher Daniel N JR | Pres, COO | J - Other | $0.00 | -10.5K | 47.0K | -18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-12-05 | J | D | 10,465 | $0.00 | 46,984 | D | — | — | (F2) Includes 147 and 51 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31 and November 30, 2022, respectively. |